MCL-1 is a master regulator of cancer dependency on fatty acid oxidation

Area of Science:

• Cancer Biology
• Cell Metabolism
• Molecular Oncology

Background:

• MCL-1 is a key anti-apoptotic protein crucial for cancer cell survival and chemoresistance.
• The exact reasons for MCL-1's significant role in cancer, beyond blocking cell death, are not fully understood.
• Understanding MCL-1's broader functions may reveal new therapeutic targets.

Purpose of the Study:

• To investigate the non-apoptotic functions of MCL-1 in cancer.
• To determine if MCL-1 regulates cancer cell metabolism.
• To explore the potential of targeting metabolic pathways in MCL-1-driven cancers.

Main Methods:

• Metabolomic, proteomic, and genomic profiling of leukemia cells.
• Analysis of MCL-1's role in fatty acid oxidation (FAO).
• Genetic deletion of Mcl-1 to assess its impact on cellular metabolism and survival.

Main Results:

• MCL-1-dependent hematologic cancer cells rely heavily on fatty acid oxidation (FAO) for energy.
• MCL-1's regulation of FAO is independent of its anti-apoptotic function.
• Deleting Mcl-1 downregulates FAO proteins, leading to cell death upon glucose withdrawal, even with blocked apoptosis.

Conclusions:

• MCL-1 acts as a master regulator of fatty acid oxidation (FAO) in cancer cells.
• This metabolic dependency makes MCL-1-driven cancers particularly vulnerable to FAO inhibitors.
• Targeting FAO presents a promising therapeutic avenue for hematologic malignancies driven by MCL-1.